Product logins

Find logins to all Clarivate products below.


Trauma Devices | Medtech 360 | Market Insights | Asia Pacific | 2021

Compared to other major orthopedic markets, the Asia Pacific trauma device market will be somewhat less severely impacted by the COVID-19 pandemic given the urgent nature of many trauma cases. Although trauma device market will be limited by pricing pressures and a challenging reimbursement environment and nationalist policies in China and India, once the market stabilizes, advancements in medical facilities and MNCs increasingly focusing on physician training will lead to overall trauma device market expansion through 2029.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for trauma devices in the Asia Pacific region across a 10-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Asia Pacific
The Asia Pacific laparoscopic device market will experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative premium priced…
Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Diabetes Care Devices – Market Insights – Asia Pacific
The Asia Pacific diabetes care device market is expected to experience moderate growth over the forecast period, driven by a rising diabetes population, untapped market opportunities, regulatory…
Report
Trauma Devices – Market Insights – Asia Pacific
The Asia Pacific trauma device market is experiencing steady growth driven by a rising incidence of fractures, an aging population, and increasing rates of road traffic accidents, particularly in…
Report
Transcatheter Embolization and Occlusion Devices – Market Insights – Asia Pacific
The Asia Pacific TEO device market will experience steady growth over the forecast period, driven by rising cancer incidence, increasing preference for minimally invasive procedures, and clinical…